Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 15, 2020

SELL
$1.77 - $2.57 $208,482 - $302,712
-117,787 Closed
0 $0
Q3 2019

Oct 29, 2019

SELL
$1.57 - $4.43 $18,840 - $53,160
-12,000 Reduced 9.25%
117,787 $217,000
Q2 2019

Jul 22, 2019

SELL
$4.39 - $5.61 $45,682 - $58,377
-10,406 Reduced 7.42%
129,787 $0
Q4 2018

Jan 18, 2019

SELL
$3.85 - $6.3 $46,200 - $75,600
-12,000 Reduced 7.88%
140,193 $658,000
Q3 2018

Oct 17, 2018

BUY
$6.0 - $9.15 $240,000 - $366,000
40,000 Added 35.65%
152,193 $966,000
Q2 2018

Jul 24, 2018

BUY
$5.33 - $7.24 $597,988 - $812,277
112,193 New
112,193 $760,000

Others Institutions Holding IRIX

About IRIDEX CORP


  • Ticker IRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 15,985,600
  • Market Cap $22.2M
  • Description
  • IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...
More about IRIX
Track This Portfolio

Track Eidelman Virant Capital Portfolio

Follow Eidelman Virant Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eidelman Virant Capital, based on Form 13F filings with the SEC.

News

Stay updated on Eidelman Virant Capital with notifications on news.